ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHEUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTR01

Stem Cell-based Modeling of Placental Defects associated with Early-Onset Preeclampsia

Active
Institution
UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA
Principal investigator
Mariko Horii
Funding
$596K
Duration
2024–2029
Open portfolio

Moonbase score

Still being scored

Abstract

Project Summary/Abstract Preeclampsia (PE) is a multifactorial pregnancy syndrome that affects up to 10% of pregnancies worldwide, and is defined by new onset of hypertension and proteinuria or end-organ dysfunction appearing after 20 weeks of gestation. Although the well-accepted underlying pathophysiology of this disease involves both maternal and fetal/placental factors, the symptoms resolve following the delivery of the placenta pointing to the importance of placental involvement in this disease. The placental histological phenotype of PE is known to have a wide range of lesions. Maternal vascular malperfusion (MVM), one of the predominant placental injuries associated with PE, is known for abnormal syncytiotrophoblast and extravillous trophoblast differentiation and function, with some cases overlapping with fetal vascular malperfusion (FVM). However, the detailed underlying molecular and cellular pathophysiology associated with PE placenta showing MVM, with or without FVM, is not well-understood. Therefore, we have set the following three aims in this proposal, combining a novel trophoblast modeling system, the molecular characterization of the placenta, and evaluate influence of mesenchymal stem/stromal cells (MSC) at the chorionic villi and elucidate the detailed mechanism associated with this pathology. Aim 1 will identify the optimal stem cell-based method to study abnormal trophoblast differentiation in PE placenta. Aim 2 will focus on in-depth characterization of PE- MVM placentas with or without FVM, and bank and characterize the cellular phenotype of each MVM subtypes of umbilical cord-derived MSCs. Aim 3 will evaluate the trophoblast-MSC crosstalk within the chorionic villi of PE placentas with different MVM-subtypes. The successful completion of this proposal will establish subtype-specific cell-based models of PE, providing effective tools for identifying diagnostic biomarkers and therapeutic targets for each sutypes, leading us to the better pregnancy care for woman and babies.

LOADING MOONBASE SCORE

R01EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTPregnancy and Neonatology Study Section[PN]fetalabnormalpregnancyplacentapreeclampsiatrophoblastplacentalcell-based

Questions for UNIVERSITY OF CALIFORNIA, SAN DIEGO

Answered by the team behind this research.

Same institution, same topic, scored first.